In 2011, The Lancet published an important article by Schwartländer and others which proposed an improved investment approach for an effective response to HIV/AIDS. This approach has profound implications for funders of the international response to HIV, including DFID. However, in order to make investment decisions under this framework, funders need sound evidence about the effectiveness and efficiency of particular interventions. Many funders expect such evidence to come from evaluations but, to date, evidence from HIV-related evaluations has been quite limited; where available, evidence has tended to appear in a fragmented and sporadic manner rather than in a systematic or coordinated way.
This report shows that a great deal of evidence is being generated through HIV-related evaluations and this can be collated effectively through a synthesis process. If this were done on a regular basis, it could provide the evidence needed for funders to make appropriate HIV-related investment decisions. Further, although there are agreed standards for evaluations in international development, these are often not met, e.g. in terms of quality of reports or the inclusion of specific recommendations. These gaps are particularly acute in the area of HIV prevention. Discussion is needed to determine which types of evaluation evidence are useful for determining policy and practice.
Drew, R. HIV/AIDS Evaluations Synthesis Report 2012. (2012) 95 pp.